BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Allied Minds Establishes New Company to Commercialize Novel University of California, Irvine Tinnitus Therapy


6/11/2009 11:22:59 AM

BOSTON, June 11 /PRNewswire/ -- Allied Minds has established SoundCure, Inc. to improve the lives of people suffering from tinnitus (ringing in the ear). Allied Minds, a seed investment corporation specializing in early stage university business ventures, will provide the initial funding and has partnered with the University of California at Irvine to establish SoundCure, LLC to commercialize a novel acoustic therapy for the treatment and suppression of tinnitus originally developed at UC Irvine.

Tinnitus is a debilitating disease characterized by a ringing in the ear in the absence of any external sound. It is believed that over 17% of the general population suffers from tinnitus and based on a recent report from the Department of Veterans Affairs, tinnitus is now the #1 disability affecting returning troops. While tinnitus can affect anyone, it is more common with increasing age and occurs at higher rates with individuals who work in noisy environments or listen to loud music for prolonged periods of time.

SoundCure is actively developing technology that was first pioneered at the University of California at Irvine by Dr. Fan-Gang Zeng and Dr. Qing Tang as a treatment to quiet the ringing in their patient's ears. Of the many available treatments for tinnitus few can provide any relief beyond simple masking (providing a sound louder than the tinnitus) while others require the use of long retraining regimes or the use of powerful drugs with similarly dangerous side effects. The SoundCure technology does not require sounds louder than the tinnitus being treated and uses customized sound frequencies and pulsed tones to counter the effects of tinnitus. The technology has shown to provide long-term suppression of tinnitus through treatment.

"We are very excited about the contribution that SoundCure will make to stem the terribly debilitating affects tinnitus has on its patients. SoundCure will also pioneer a transformational way technology can be applied to treat disease and provide patient care only dreamt of in the past," said Allied Minds COO, Marc Eichenberger. To learn more about SoundCure please visit www.soundcure.com.

About Allied Minds, Inc.

Allied Minds is a seed investment company creating partnerships with select universities to fund corporate spin-offs resulting from successful early stage technology research. By providing corporate development support as well as funding, Allied Minds aims to guide early stage companies to commercial success, thereby generating value for all stakeholders. For more information, logon to www.alliedminds.com.

About the UC Irvine, Office of Technology Alliances

The UCI Office of Technology Alliances (OTA) exists to foster faculty/industry alliances and commercialization of UC Irvine technology for the broad public benefit. OTA emphasizes accessibility, timeliness, and flexibility in its operations and negotiations to ensure that the federal, state and private investment in UCI research has the greatest possible positive impact on people and the economy.

CONTACT: Marc Eichenberger, COO of Allied Minds, Inc, +1-781-353-6404,
marc.eichenberger@alliedminds.com; or Ronnie Hanecak, Director, Life
Sciences, Office of Technology Alliances, +1-949-824-1233, rhanecak@uci.edu

Web site: http://www.alliedminds.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES